111 related articles for article (PubMed ID: 9292816)
1. Interferon-alpha associated arthritis.
Chung A; Older SA
J Rheumatol; 1997 Sep; 24(9):1844-5. PubMed ID: 9292816
[TBL] [Abstract][Full Text] [Related]
2. Arthritis in a patient with psoriasis after interferon-alpha therapy for chronic hepatitis C.
Makino Y; Tanaka H; Nakamura K; Fujita M; Akiyama K; Makino I
J Rheumatol; 1994 Sep; 21(9):1771-2. PubMed ID: 7799367
[TBL] [Abstract][Full Text] [Related]
3. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review.
Boonyapisit K; Katirji B
Muscle Nerve; 2002 Jun; 25(6):909-13. PubMed ID: 12115983
[TBL] [Abstract][Full Text] [Related]
4. [Multiple extrahepatic manifestations in a patient with chronic hepatitis C treated with interferon-alfa].
Napoli N; Tortorella C; Deramo MT; Antonaci A; Parisi CV; Antonaci S
Recenti Prog Med; 2004 Nov; 95(11):525-8. PubMed ID: 15598090
[TBL] [Abstract][Full Text] [Related]
5. [Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature].
Téllez-Zenteno JF; Negrete-Pulido O; Nuñez M; Estañol-Vidal B; García-Ramos G
Rev Neurol; 2002 Oct 1-15; 35(7):644-6. PubMed ID: 12389150
[TBL] [Abstract][Full Text] [Related]
6. Chronic paranoid psychosis and dementia following interferon-alpha treatment of hepatitis C: a case report.
Drozdz W; Borkowska A; Wilkosc M; Halota W; Dybowska D; Rybakowski JK
Pharmacopsychiatry; 2007 Jul; 40(4):146-8. PubMed ID: 17694476
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection.
Wilson LE; Widman D; Dikman SH; Gorevic PD
Semin Arthritis Rheum; 2002 Dec; 32(3):163-73. PubMed ID: 12528081
[TBL] [Abstract][Full Text] [Related]
8. Fulminant central nervous system demyelination associated with interferon-alpha therapy and hepatitis C virus infection.
Höftberger R; Garzuly F; Dienes HP; Grubits J; Rohonyi B; Fischer G; Hanzely Z; Lassmann H; Budka H
Mult Scler; 2007 Nov; 13(9):1100-6. PubMed ID: 17967838
[TBL] [Abstract][Full Text] [Related]
9. Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.
Martocchia A; Labbadia G; Paoletti V; Gargano S; Grossi A; Trabace S; Musca A; Falaschi P
Neuro Endocrinol Lett; 2001; 22(1):49-52. PubMed ID: 11335880
[TBL] [Abstract][Full Text] [Related]
10. Acute exacerbation of antiliver cytosol antibody-positive autoimmune chronic hepatitis by alpha-interferon.
Gschwantler M; Schrutka-Kölbl C; Weiss W
Am J Gastroenterol; 1995 Dec; 90(12):2239-40. PubMed ID: 8540531
[No Abstract] [Full Text] [Related]
11. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune thrombocytopenia induced by PEG-IFN-alpha plus ribavirin in hepatitis C.
Demirturk N; Cevik F; Demirdal T; Aykin N; Aslan V
Platelets; 2006 Aug; 17(5):340-3. PubMed ID: 16928608
[TBL] [Abstract][Full Text] [Related]
13. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
[TBL] [Abstract][Full Text] [Related]
14. Psychosis in a methadone-substituted patient during interferon-alpha treatment of hepatitis C.
Schäfer M; Boetsch T; Laakmann G
Addiction; 2000 Jul; 95(7):1101-4. PubMed ID: 10962774
[TBL] [Abstract][Full Text] [Related]
15. Polyarthritis following interferon alpha treatment in a patient with localized Wegener's granulomatosis.
Reinhold-Keller E; Lamprecht P; Feller AC; Gross WL
Clin Exp Rheumatol; 2001; 19(2):227-8. PubMed ID: 11326494
[No Abstract] [Full Text] [Related]
16. Restless legs syndrome due to interferon-alpha.
LaRochelle JS; Karp BI
Mov Disord; 2004 Jun; 19(6):730-1. PubMed ID: 15197722
[TBL] [Abstract][Full Text] [Related]
17. Interferon-induced sarcoidosis.
Doyle MK; Berggren R; Magnus JH
J Clin Rheumatol; 2006 Oct; 12(5):241-8. PubMed ID: 17023810
[TBL] [Abstract][Full Text] [Related]
18. [Thyroid disorders associated with interferon treatment in patients with chronic viral hepatitis or multiple sclerosis].
Diago JI; del Olmo D; Alcázar V; Martínez de Icaya P; Rodríguez E; Martínez Montiel P
Med Clin (Barc); 1999 Jun; 113(2):50-1. PubMed ID: 10425619
[TBL] [Abstract][Full Text] [Related]
19. [Hypothyroidism as a complication of the treatment of hepatitis C with interferon].
Gomollón García F; Simón Marco MA; Vela J; García López S; Fuentes Olmo J
An Med Interna; 1996 Sep; 13(9):438-40. PubMed ID: 9132035
[TBL] [Abstract][Full Text] [Related]
20. A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy.
Balan V; Nelson DR; Sulkowski MS; Everson GT; Lambiase LR; Wiesner RH; Dickson RC; Post AB; Redfield RR; Davis GL; Neumann AU; Osborn BL; Freimuth WW; Subramanian GM
Antivir Ther; 2006; 11(1):35-45. PubMed ID: 16518958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
